9 research outputs found
Excessive Post- Exercise Oxygen Consumption (EPOC) Following a Twenty-Minute Submaximal Cycle Test
According to McArdle et al. (2015), Excessive Post-Exercise Oxygen Consumption (EPOC) computes the total oxygen consumed in recovery minus the total oxygen consumed at rest during the recovery period. According to McArdle et al. (2015), VO2 mL/kg/min is defined as maximal oxygen consumption. According to McArdle et al. (2015), respiratory exchange ratio (RER) is the ratio of carbon dioxide produced to oxygen consumed under rest and steady-state conditions with little reliance on anaerobic metabolism. According to Dr. et al. (2004), EPOC is also known as O2 deficit and was used as a measure of anaerobic metabolism during exercise. According to McArdle et al. (2015), there are two forms that are used to help determine EPOC for exercise and recovery: active recovery and passive recovery. Active recovery is defined as âcooling downâ or âtapering offâ and passive recovery is where an individual usually lies down presuming that total inactivity reduces the resting energy requirements and thus âfreesâ oxygen to fuel the recovery process (McArdle et al., 2015). During this study, the individual performed a passive recovery. VÌO2 is the maximal oxygen consumption that an individual utilizes during an intense exercise (McArdle et al., 2015). Heart rate is the number of times the heart beats per minute which is based on the number of contractions of the ventricles. Pulmonary Ventilation (VE) describes the process of moving and exchanging ambient air with air in the lungs (McArdle et al., 2015). The purpose of this study was to determine if EPOC could be assessed in a 20â32-year-old college student 10 minutes after a sub max cycling test is performed. It was hypothesized that EPOC can be assessed 10 minutes after a submaximal cycle test is performed.https://digitalcommons.gardner-webb.edu/exercise-science-research-proposal-posters/1138/thumbnail.jp
Is There Evidence of Wage Inflation for Unskilled Workers in Boise, Idaho?
Our research will examine the trends in wages in unskilled jobs between the years 2010-2021 in Boise, Idaho. We will conduct an online survey, by Typeform, that will include information regarding the wage rates for unskilled positions. The surveyors will be asked a question regarding their skill level. Level one is no skill and no training (maid, babysitter), level 2 is no skill, with little training (retail, fast food). Level 3 is minimal skill (call center), level four is skill in addition to training (manager), and level 5 is skill that requires an education or degree. Within the survey, we will include demographic questions on age, family size, and the industry they are currently employed in will be asked. Other questions that will be asked will include how much money the individual makes in a year. We will then synthesize this survey data into further tangible metrics, using a desktop app called Excel, which will allow us to create charts and graphics. We will use the data from the survey to calculate the average wage of unskilled workers in Boise, Idaho. Along with the average wage, we will determine the most predominant unskilled industries in the Boise, Idaho area and the industries experiencing most wage growth. These estimates will be compared to the national averages
Bumped kinase inhibitor 1369 is effective against Cystoisospora suis in vivo and in vitro.
Cystoisosporosis is a leading diarrheal disease in suckling piglets. With the confirmation of resistance against the only available drug toltrazuril, there is a substantial need for novel therapeutics to combat the infection and its negative effects on animal health. In closely related apicomplexan species, bumped kinase inhibitors (BKIs) targeting calcium-dependent protein kinase 1 (CDPK1) were shown to be effective in inhibiting host-cell invasion and parasite growth. Therefore, the gene coding for Cystoisospora suis CDPK1 (CsCDPK1) was identified and cloned to investigate activity and thermal stabilization of the recombinant CsCDPK1 enzyme by BKI 1369. In this comprehensive study, the efficacy, safety and pharmacokinetics of BKI 1369 in piglets experimentally infected with Cystoisospora suis (toltrazuril-sensitive, Wien-I and toltrazuril-resistant, Holland-I strains) were determined in vivo and in vitro using an established animal infection model and cell culture, respectively. BKI 1369 inhibited merozoite proliferation in intestinal porcine epithelial cells-1 (IPEC-1) by at least 50% at a concentration of 40âŻnM, and proliferation was almost completely inhibited (>95%) at 200âŻnM. Nonetheless, exposure of infected cultures to 200âŻnM BKI 1369 for five days did not induce structural alterations in surviving merozoites as confirmed by transmission electron microscopy. Five-day treatment with BKI 1369 (10âŻmg/kg BW twice a day) effectively suppressed oocyst excretion and diarrhea and improved body weight gains in treated piglets without obvious side effects for both toltrazuril-sensitive, Wien-I and resistant, Holland-I C. suis strains. The plasma concentration of BKI 1369 in piglets increased to 11.7âŻÎŒM during treatment, suggesting constant drug accumulation and exposure of parasites to the drug. Therefore, oral applications of BKI 1369 could potentially be a therapeutic alternative against porcine cystoisosporosis. For use in pigs, future studies on BKI 1369 should be directed towards ease of drug handling and minimizing treatment frequencies
Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba.
Naegleria fowleri is a pathogenic, thermophilic, free-living amoeba which causes primary amebic meningoencephalitis (PAM). Penetrating the olfactory mucosa, the brain-eating amoeba travels along the olfactory nerves, burrowing through the cribriform plate to its destination: the brain's frontal lobes. The amoeba thrives in warm, freshwater environments, with peak infection rates in the summer months and has a mortality rate of approximately 97%. A major contributor to the pathogen's high mortality is the lack of sensitivity of N. fowleri to current drug therapies, even in the face of combination-drug therapy. To enable rational drug discovery and design efforts we have pursued protein production and crystallography-based structure determination efforts for likely drug targets from N. fowleri. The genes were selected if they had homology to drug targets listed in Drug Bank or were nominated by primary investigators engaged in N. fowleri research. In 2017, 178 N. fowleri protein targets were queued to the Seattle Structural Genomics Center of Infectious Disease (SSGCID) pipeline, and to date 89 soluble recombinant proteins and 19 unique target structures have been produced. Many of the new protein structures are potential drug targets and contain structural differences compared to their human homologs, which could allow for the development of pathogen-specific inhibitors. Five of the structures were analyzed in more detail, and four of five show promise that selective inhibitors of the active site could be found. The 19 solved crystal structures build a foundation for future work in combating this devastating disease by encouraging further investigation to stimulate drug discovery for this neglected pathogen
Shotgun Kinetic Target-Guided Synthesis Approach Enables the Discovery of Small-Molecule Inhibitors against Pathogenic Free-Living Amoeba Glucokinases
Pathogenic free-living amoebae (pFLA) can cause life-threatening
central nervous system (CNS) infections and warrant the investigation
of new chemical agents to combat the rise of infection from these
pathogens. Naegleria fowleri glucokinase
(NfGlck), a key metabolic enzyme involved in generating
glucose-6-phosphate, was previously identified as a potential target
due to its limited sequence similarity with human Glck (HsGlck). Herein, we used our previously demonstrated multifragment
kinetic target-guided synthesis (KTGS) screening strategy to identify
inhibitors against pFLA glucokinases. Unlike the majority of previous
KTGS reports, our current study implements a âshotgunâ
approach, where fragments were not biased by predetermined binding
potentials. The study resulted in the identification of 12 inhibitors
against 3 pFLA glucokinase enzymesNfGlck, Balamuthia mandrillaris Glck (BmGlck), and Acanthamoeba castellanii Glck (AcGlck). This work demonstrates the utility
of KTGS to identify small-molecule binders for biological targets
where resolved X-ray crystal structures are not readily accessible
Shotgun Kinetic Target-Guided Synthesis Approach Enables the Discovery of Small-Molecule Inhibitors against Pathogenic Free-Living Amoeba Glucokinases
Pathogenic free-living amoebae (pFLA) can cause life-threatening
central nervous system (CNS) infections and warrant the investigation
of new chemical agents to combat the rise of infection from these
pathogens. Naegleria fowleri glucokinase
(NfGlck), a key metabolic enzyme involved in generating
glucose-6-phosphate, was previously identified as a potential target
due to its limited sequence similarity with human Glck (HsGlck). Herein, we used our previously demonstrated multifragment
kinetic target-guided synthesis (KTGS) screening strategy to identify
inhibitors against pFLA glucokinases. Unlike the majority of previous
KTGS reports, our current study implements a âshotgunâ
approach, where fragments were not biased by predetermined binding
potentials. The study resulted in the identification of 12 inhibitors
against 3 pFLA glucokinase enzymesNfGlck, Balamuthia mandrillaris Glck (BmGlck), and Acanthamoeba castellanii Glck (AcGlck). This work demonstrates the utility
of KTGS to identify small-molecule binders for biological targets
where resolved X-ray crystal structures are not readily accessible
Abstracts of the 3rd Annual Graduate Entry Research in Medicine Conference
This book contains the abstracts of the papers presented at The 3rd Annual Graduate Entry Research in Medicine Conference (GERMCON 2020) Organized by Warwick Medical School, University of Warwick in collaboration with Swansea University Medical School, Swansea University, Wales, UK held on 12â18 October 2020. This was especially important for Graduate Entry Medical (GEM) students, who have less opportunity and time to engage in research due to their accelerated medical degree.
Conference Title: 3rd Annual Graduate Entry Research in Medicine ConferenceConference Acronym: GERMCON 2020Conference Date: 12â18 October 2020Conference Location:Â Online (Virtual Mode)Conference Organizer: Warwick Medical School, University of Warwick, UKCo-organizer: Swansea University Medical School, Swansea University, Wales, UK
Other Abstract Book of GERMCON: Abstracts of the 4th Annual Graduate Entry Research in Medicine Conferenc
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
Circulating tumour DNA (ctDNA) can be used to detect and profile residual tumour cells persisting after curative intent therapy1. The study of large patient cohorts incorporating longitudinal plasma sampling and extended follow-up is required to determine the role of ctDNA as a phylogenetic biomarker of relapse in early-stage non-small-cell lung cancer (NSCLC). Here we developed ctDNA methods tracking a median of 200 mutations identified in resected NSCLC tissue across 1,069 plasma samples collected from 197 patients enrolled in the TRACERx study2. A lack of preoperative ctDNA detection distinguished biologically indolent lung adenocarcinoma with good clinical outcome. Postoperative plasma analyses were interpreted within the context of standard-of-care radiological surveillance and administration of cytotoxic adjuvant therapy. Landmark analyses of plasma samples collected within 120âdays after surgery revealed ctDNA detection in 25% of patients, including 49% of all patients who experienced clinical relapse; 3 to 6 monthly ctDNA surveillance identified impending disease relapse in an additional 20% of landmark-negative patients. We developed a bioinformatic tool (ECLIPSE) for non-invasive tracking of subclonal architecture at low ctDNA levels. ECLIPSE identified patients with polyclonal metastatic dissemination, which was associated with a poor clinical outcome. By measuring subclone cancer cell fractions in preoperative plasma, we found that subclones seeding future metastases were significantly more expanded compared with non-metastatic subclones. Our findings will support (neo)adjuvant trial advances and provide insights into the process of metastatic dissemination using low-ctDNA-level liquid biopsy